Detalhe da pesquisa
1.
SGLT2 inhibitor empagliflozin promotes revascularization in diabetic mouse hindlimb ischemia by inhibiting ferroptosis.
Acta Pharmacol Sin
; 44(6): 1161-1174, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36509902
2.
Intramuscular injection of sotagliflozin promotes neovascularization in diabetic mice through enhancing skeletal muscle cells paracrine function.
Acta Pharmacol Sin
; 43(10): 2636-2650, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35292769